Metabolic abnormalities in impaired glucose tolerance

Metabolism: Clinical and Experimental

Volumn 46, Issue SUPPL.1, 1997, Pages 40-43

  Gerich, John E ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ARTICLE; DIABETES MELLITUS; DIABETOGENESIS; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0031421292     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0026-0495(97)90316-4     Document Type: Article

References (36)

1. World Health Organization Expert Committee: Second report on diabetes mellitus. World Health Organ Tech Rep Ser 641-646, 1980
2. Harris M: Impaired glucose tolerance - Prevalence and conversion to NIDDM. Diabet Med 13:S9-S11,1996 (suppl 2)
3. Heine R, Nijpels G, Mooy J: New data on the role of progression of impaired glucose tolerance to NIDDM and predicting factors. Diabet Med 13:S12-S14, 1996 (suppl 2)
4. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
6. Jarrett R: The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 13:S15-S19, 1996 (suppl)
7. Perry I, Wannamethee S, Walker M, et al: Prospective study of risk factors for development of non-insulin dependent diabetes in middleaged British men. Br Med J 310:560-565, 1995
8. Haffner S, Miettinen H, Gaskill S, et al: Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39:1201-1207, 1996
9. Lillioja S, Mott D, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent, diabetes mellitus: Prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
10. Butler P, Rizza R: Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients: Diabetes 40:73-81, 1991
11. Mitrakou A, Kelley D, Veneman T, et al: Role of reduced suppression of hepatic glucose output and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
12. Stumvoll M, Chintalapudi U, Perriello G, et al: Uptake and release of glucose by the human kidney: Postabsorptive rates and responses to epinephrine. J Clin Invest 96:2528-2533, 1995
13. Mitrakou A, Kelley D, Veneman T, et al: Contribution of abnormal muscle and liver glucose metabolism in postprandial hyperglycemia in noninsulin-dependent diabetes mellitus. Diabetes 39:1381-1390, 1990
14. Calles-Escandon J, Robbins D: Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes 36:1167-1172, 1987
15. Lillioja S, Mott D, Howard B, et al: Impaired glucose tolerance as a disorder of insulin action: Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
16. Yalow R, Berson R: Plasma insulin concentrations in nondiabetic and early diabetic subjects: Determinations by a new sensitive immuno-assay technique. Diabetes 9:254-260, 1960
17. Pimenta W, Mitrakou A, Yki-Jarvinen H, et al: Insulin secretion and insulin sensitivity in people with impaired glucose tolerance. Diabet Med 13:533-536, 1996
18. Davies M, Rayman G, Grenfell A, et al: Loss of the first phase insulin, response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 11:432-436, 1994
19. Kosaka K, Hogura R, Kuzuya T: Insulin responses in equivocal and definite diabetes with special reference to subjects who had mild glucose intolerance but later developed definite, diabetes. Diabetes 26:944-952, 1977
20. Eriksson K, Lindgarde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 39:573-579, 1996
21. Eriksson J, Franssila-Kallunki A, Ekstand A, et al: Early metabolic defects in persons at increased risk for noninsulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
22. Vaag A, Henriksen J, Madsbad S, et al: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
23. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
24. O'Rahilly SP, Rudenski AS, Burnett MA, et al: Beta cell dysfunction rather than insulin insensitivity is the primary defect in familial type II diabetes. Lancet 2:360-364, 1986
25. Byrne M, Sturis J, Sobel R, et al: Elevated plasma glucose 2h postchallenge predicts defects in B-cell function. Am J Physiol 270:E572-E579, 1996
26. Larsson H, Ahren B: Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 45:502-509, 1996
27. Taniguchi A, Nakai Y, Dor K, et al: Insulin sensitivity, insulin secretion, and glucose effectiveness in obese subjects: A minimal model analysis. Metabolism 44:1397-1400, 1995
28. Sacca L, Orofino G, Petrone A, et al: Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest 73:1683-1687, 1984
29. Kolterman OG, Gray RS, Griffin J, et al: Receptor and postreceptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68:957-969, 1981
30. Berrish T, Hetherington C, Alberti K, et al: Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Diabetologia 38:699-704, 1995
31. Broughton D, Webster J, Taylor R: Insulin sensitivity and secretion in healthy elderly human subjects with 'abnormal' glucose tolerance. Eur J Clin Invest 22:582-590, 1992
32. Robertson D, Singh B, Nattrass M: Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique. Diabet Med 8:718-725, 1991
33. Gerich JE: Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 34:607-610, 1991
34. Felber J, Ferrannini E, Golay A, et al: Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987
35. Vaag A, Alford F, Beck-Nielson H: Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): Acquired versus genetic metabolic defects. Diabet Med 13:806-815, 1996
36. Pimenta W, Kortytkowski M, Mitrakou A, et ai: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273:1855-1861, 1995